{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:44:35Z","timestamp":1795085075230,"version":"4.10.2"},"reference-count":83,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The 5th edition of the World Health Organization classification of digestive system tumors discusses several advancements and developments in understanding the etiology, pathogenesis, and diagnosis of several digestive tract tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To provide a summary of the updates with a focus on neuroendocrine neoplasms, appendiceal tumors, and the molecular advances in tumors of the digestive system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>English literature and personal experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Some of the particularly important updates in the 5th edition are the alterations made in the classification of neuroendocrine neoplasms, understanding of pathogenesis of appendiceal tumors and their precursor lesions, and the expanded role of molecular pathology in establishing an accurate diagnosis or predicting prognosis and response to treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2019-0665-ra","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T17:06:41Z","timestamp":1585760801000},"page":"664-677","source":"Crossref","is-referenced-by-count":181,"title":["What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing"],"prefix":"10.5858","volume":"145","author":[{"given":"Naziheh","family":"Assarzadegan","sequence":"first","affiliation":[{"name":"Department of Pathology, the Johns Hopkins University, School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Department of Pathology, the Johns Hopkins University, School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"2021052618104376600_i1543-2165-145-6-664-b01","doi-asserted-by":"crossref","unstructured":"Basturk\n              O,\n            \n            \n              Yang\n              Z,\n            \n            \n              Tang\n              LH,\n            \n            et al.\n          \n          The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2015;\n\t\t\t\t\t39(5):\n\t\t\t\t\t683\u2013\n\t\t\t\t\t690.","DOI":"10.1097\/PAS.0000000000000408"},{"key":"2021052618104376600_i1543-2165-145-6-664-b02","doi-asserted-by":"crossref","unstructured":"Nagtegaal\n              ID,\n            \n            \n              Odze\n              RD,\n            \n            \n              Klimstra\n              D,\n            \n            et al;\n          \n          for the WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system.\n\t\t\t\t\tHistopathology.\n\t\t\t\t\t2020;\n\t\t\t\t\t76(2):\n\t\t\t\t\t182\u2013\n\t\t\t\t\t188.","DOI":"10.1111\/his.13975"},{"key":"2021052618104376600_i1543-2165-145-6-664-b03","doi-asserted-by":"crossref","unstructured":"Kim\n              JY,\n            \n            \n              Hong\n              S.\n            \n          \n          Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts.\n\t\t\t\t\tArch Pathol Lab Med.\n\t\t\t\t\t2016;\n\t\t\t\t\t140(5):\n\t\t\t\t\t437\u2013\n\t\t\t\t\t448.","DOI":"10.5858\/arpa.2015-0314-RA"},{"key":"2021052618104376600_i1543-2165-145-6-664-b04","doi-asserted-by":"crossref","unstructured":"Rindi\n              G,\n            \n            \n              Klimstra\n              DS,\n            \n            \n              Abedi-Ardekani\n              B,\n            \n            et al.\n          \n          A common classification framework for neuroendocrine neoplasms: an international agency for research on cancer (IARC) and world health organization (WHO) expert consensus proposal.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2018;\n\t\t\t\t\t31(12):\n\t\t\t\t\t1770\u2013\n\t\t\t\t\t1786.","DOI":"10.1038\/s41379-018-0110-y"},{"key":"2021052618104376600_i1543-2165-145-6-664-b05","unstructured":"Lokuhetty\n              D,\n            \n            \n              White\n              V,\n            \n            \n              Watanabe\n              R,\n            \n            \n              Cree\n              I.\n            \n          \n          \n            WHO classification of tumours of the digestive system\n          .\n\t\t\t\t\tLyon:\n\t\t\t\t\tInternational Agency for Research on Cancer;2018."},{"key":"2021052618104376600_i1543-2165-145-6-664-b06","doi-asserted-by":"crossref","unstructured":"Strosberg\n              JR,\n            \n            \n              Coppola\n              D,\n            \n            \n              Klimstra\n              DS,\n            \n            et al.\n          \n          The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.\n\t\t\t\t\tPancreas.\n\t\t\t\t\t2010;\n\t\t\t\t\t39(6):\n\t\t\t\t\t799\u2013\n\t\t\t\t\t800.","DOI":"10.1097\/MPA.0b013e3181ebb56f"},{"key":"2021052618104376600_i1543-2165-145-6-664-b07","doi-asserted-by":"crossref","unstructured":"Kunz\n              PL,\n            \n            \n              Mojtahed\n              A,\n            \n            \n              Fisher\n              GA,\n            \n            et al.\n          \n          HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.\n\t\t\t\t\tAppl Immunohistochem Mol Morphol.\n\t\t\t\t\t2012;\n\t\t\t\t\t20(1):\n\t\t\t\t\t13\u2013\n\t\t\t\t\t24.","DOI":"10.1097\/PAI.0b013e31821c821c"},{"key":"2021052618104376600_i1543-2165-145-6-664-b08","doi-asserted-by":"crossref","unstructured":"Scoazec\n              J,\n            \n            \n              Couvelard\n              A.\n            \n          \n          Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future [in French].\n\t\t\t\t\tAnn Pathol.\n\t\t\t\t\t2017;\n\t\t\t\t\t37(6):\n\t\t\t\t\t444\u2013\n\t\t\t\t\t456.","DOI":"10.1016\/j.annpat.2017.10.003"},{"key":"2021052618104376600_i1543-2165-145-6-664-b09","doi-asserted-by":"crossref","unstructured":"Tang\n              LH,\n            \n            \n              Untch\n              BR,\n            \n            \n              Reidy\n              DL,\n            \n            et al.\n          \n          Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas.\n\t\t\t\t\tClin Cancer Res.\n\t\t\t\t\t2016;\n\t\t\t\t\t22(4):\n\t\t\t\t\t1011\u2013\n\t\t\t\t\t1017.","DOI":"10.1158\/1078-0432.CCR-15-0548"},{"key":"2021052618104376600_i1543-2165-145-6-664-b10","doi-asserted-by":"crossref","unstructured":"van Velthuysen\n              MF,\n            \n            \n              Groen\n              EJ,\n            \n            \n              van der Noort\n              V,\n            \n            \n              van de Pol\n              A,\n            \n            \n              Tesselaar\n              MET,\n            \n            \n              Korse\n              CM.\n            \n          \n          Grading of neuroendocrine neoplasms: mitoses and ki-67 are both essential.\n\t\t\t\t\tNeuroendocrinology.\n\t\t\t\t\t2014;\n\t\t\t\t\t100(2-3):\n\t\t\t\t\t221\u2013\n\t\t\t\t\t227.","DOI":"10.1159\/000369275"},{"key":"2021052618104376600_i1543-2165-145-6-664-b11","doi-asserted-by":"crossref","unstructured":"La Rosa\n              S,\n            \n            \n              Sessa\n              F,\n            \n            \n              Uccella\n              S.\n            \n          \n          Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms.\n\t\t\t\t\tEndocr Pathol.\n\t\t\t\t\t2016;\n\t\t\t\t\t27(4):\n\t\t\t\t\t284\u2013\n\t\t\t\t\t311.","DOI":"10.1007\/s12022-016-9432-9"},{"key":"2021052618104376600_i1543-2165-145-6-664-b12","doi-asserted-by":"crossref","unstructured":"Jiao\n              Y,\n            \n            \n              Shi\n              C,\n            \n            \n              Edil\n              BH,\n            \n            et al.\n          \n          DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.\n\t\t\t\t\tScience.\n\t\t\t\t\t2011;\n\t\t\t\t\t331(6021):\n\t\t\t\t\t1199\u2013\n\t\t\t\t\t1203.","DOI":"10.1126\/science.1200609"},{"key":"2021052618104376600_i1543-2165-145-6-664-b13","doi-asserted-by":"crossref","unstructured":"Konukiewitz\n              B,\n            \n            \n              Schlitter\n              AM,\n            \n            \n              Jesinghaus\n              M,\n            \n            et al.\n          \n          Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2017;\n\t\t\t\t\t30(4):\n\t\t\t\t\t587\u2013\n\t\t\t\t\t598.","DOI":"10.1038\/modpathol.2016.217"},{"key":"2021052618104376600_i1543-2165-145-6-664-b14","doi-asserted-by":"crossref","unstructured":"Yachida\n              S,\n            \n            \n              Vakiani\n              E,\n            \n            \n              White\n              CM,\n            \n            et al.\n          \n          Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2012;\n\t\t\t\t\t36(2):\n\t\t\t\t\t173\u2013\n\t\t\t\t\t184.","DOI":"10.1097\/PAS.0b013e3182417d36"},{"key":"2021052618104376600_i1543-2165-145-6-664-b15","doi-asserted-by":"crossref","unstructured":"Scarpa\n              A,\n            \n            \n              Chang\n              DK,\n            \n            \n              Nones\n              K,\n            \n            et al.\n          \n          Whole-genome landscape of pancreatic neuroendocrine tumours.\n\t\t\t\t\tNature.\n\t\t\t\t\t2017;\n\t\t\t\t\t543(7643):\n\t\t\t\t\t65\u2013\n\t\t\t\t\t71.","DOI":"10.1038\/nature21063"},{"key":"2021052618104376600_i1543-2165-145-6-664-b16","doi-asserted-by":"crossref","unstructured":"Singhi\n              AD,\n            \n            \n              Klimstra\n              DS.\n            \n          \n          Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): Concepts, issues and a practical diagnostic approach to high-grade (G3) cases.\n\t\t\t\t\tHistopathology.\n\t\t\t\t\t2018;\n\t\t\t\t\t72(1):\n\t\t\t\t\t168\u2013\n\t\t\t\t\t177.","DOI":"10.1111\/his.13408"},{"key":"2021052618104376600_i1543-2165-145-6-664-b17","doi-asserted-by":"crossref","unstructured":"Mafficini\n              A,\n            \n            \n              Scarpa\n              A.\n            \n          \n          Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms.\n\t\t\t\t\tEndocr Rev.\n\t\t\t\t\t2019;\n\t\t\t\t\t40(2):\n\t\t\t\t\t506\u2013\n\t\t\t\t\t536.","DOI":"10.1210\/er.2018-00160"},{"key":"2021052618104376600_i1543-2165-145-6-664-b18","doi-asserted-by":"crossref","unstructured":"Shia\n              J,\n            \n            \n              Tang\n              LH,\n            \n            \n              Weiser\n              MR,\n            \n            et al.\n          \n          Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?\n          \n            Am J Surg Pathol\n          .\n\t\t\t\t\t2008;\n\t\t\t\t\t32(5):\n\t\t\t\t\t719\u2013\n\t\t\t\t\t731.","DOI":"10.1097\/PAS.0b013e318159371c"},{"key":"2021052618104376600_i1543-2165-145-6-664-b19","doi-asserted-by":"crossref","unstructured":"Kimura\n              W,\n            \n            \n              Kuroda\n              A,\n            \n            \n              Morioka\n              Y.\n            \n          \n          Clinical pathology of endocrine tumors of the pancreas. analysis of autopsy cases.\n\t\t\t\t\tDig Dis Sci.\n\t\t\t\t\t1991;\n\t\t\t\t\t36(7):\n\t\t\t\t\t933\u2013\n\t\t\t\t\t942.","DOI":"10.1007\/BF01297144"},{"key":"2021052618104376600_i1543-2165-145-6-664-b20","doi-asserted-by":"crossref","unstructured":"Basturk\n              O,\n            \n            \n              Tang\n              L,\n            \n            \n              Hruban\n              RH,\n            \n            et al.\n          \n          Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t38(4):\n\t\t\t\t\t437\u2013\n\t\t\t\t\t447.","DOI":"10.1097\/PAS.0000000000000169"},{"key":"2021052618104376600_i1543-2165-145-6-664-b21","unstructured":"Lioyd\n              RV,\n            \n            \n              Osamura\n              RY,\n            \n            \n              Kloppel\n              G.\n            \n          \n          \n            WHO classification of tumours of endocrine organs\n          .\n\t\t\t\t\tLyon:\n\t\t\t\t\tInternational Agency for Research on Cancer;2010."},{"key":"2021052618104376600_i1543-2165-145-6-664-b22","doi-asserted-by":"crossref","unstructured":"Esposito\n              I,\n            \n            \n              Segler\n              A,\n            \n            \n              Steiger\n              K,\n            \n            \n              Kl\u00f6ppel\n              G.\n            \n          \n          Pathology, genetics and precursors of human and experimental pancreatic neoplasms: an update.\n\t\t\t\t\tPancreatology.\n\t\t\t\t\t2015;\n\t\t\t\t\t15(6):\n\t\t\t\t\t598\u2013\n\t\t\t\t\t610.","DOI":"10.1016\/j.pan.2015.08.007"},{"key":"2021052618104376600_i1543-2165-145-6-664-b23","doi-asserted-by":"crossref","unstructured":"Modlin\n              IM,\n            \n            \n              Shapiro\n              MD,\n            \n            \n              Kidd\n              M.\n            \n          \n          An analysis of rare carcinoid tumors: clarifying these clinical conundrums.\n\t\t\t\t\tWorld J Surg.\n\t\t\t\t\t2005;\n\t\t\t\t\t29(1):\n\t\t\t\t\t92\u2013\n\t\t\t\t\t101.","DOI":"10.1007\/s00268-004-7443-z"},{"key":"2021052618104376600_i1543-2165-145-6-664-b24","doi-asserted-by":"crossref","unstructured":"Maru\n              DM,\n            \n            \n              Khurana\n              H,\n            \n            \n              Rashid\n              A,\n            \n            et al.\n          \n          Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2008;\n\t\t\t\t\t32(9):\n\t\t\t\t\t1404\u2013\n\t\t\t\t\t1411.","DOI":"10.1097\/PAS.0b013e31816bf41f"},{"key":"2021052618104376600_i1543-2165-145-6-664-b25","unstructured":"Estrozi\n              B,\n            \n            \n              Bacchi\n              CE.\n            \n          \n          Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases.\n\t\t\t\t\tClinics (Sao Paulo).\n\t\t\t\t\t2011;\n\t\t\t\t\t66(10):\n\t\t\t\t\t1671\u2013\n\t\t\t\t\t1675."},{"key":"2021052618104376600_i1543-2165-145-6-664-b26","doi-asserted-by":"crossref","unstructured":"Hoang\n              MP,\n            \n            \n              Hobbs\n              CM,\n            \n            \n              Sobin\n              LH,\n            \n            \n              Albores-Saavedra\n              J.\n            \n          \n          Carcinoid tumor of the esophagus: a clinicopathologic study of four cases.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2002;\n\t\t\t\t\t26(4):\n\t\t\t\t\t517\u2013\n\t\t\t\t\t522.","DOI":"10.1097\/00000478-200204000-00016"},{"key":"2021052618104376600_i1543-2165-145-6-664-b27","doi-asserted-by":"crossref","unstructured":"Yang\n              Z,\n            \n            \n              Wang\n              W,\n            \n            \n              Lu\n              J,\n            \n            et al.\n          \n          Gastric neuroendocrine tumors (G-nets): incidence, prognosis and recent trend toward improved survival.\n\t\t\t\t\tCell Physiol Biochem.\n\t\t\t\t\t2018;\n\t\t\t\t\t45(1):\n\t\t\t\t\t389\u2013\n\t\t\t\t\t396.","DOI":"10.1159\/000486915"},{"key":"2021052618104376600_i1543-2165-145-6-664-b28","doi-asserted-by":"crossref","unstructured":"La Rosa\n              S,\n            \n            \n              Vanoli\n              A.\n            \n          \n          Gastric neuroendocrine neoplasms and related precursor lesions.\n\t\t\t\t\tJ Clin Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t67(11):\n\t\t\t\t\t938\u2013\n\t\t\t\t\t948.","DOI":"10.1136\/jclinpath-2014-202515"},{"key":"2021052618104376600_i1543-2165-145-6-664-b29","doi-asserted-by":"crossref","unstructured":"Rindi\n              G,\n            \n            \n              Luinetti\n              O,\n            \n            \n              Cornaggia\n              M,\n            \n            \n              Capella\n              C,\n            \n            \n              Solcia\n              E.\n            \n          \n          Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.\n\t\t\t\t\tGastroenterology.\n\t\t\t\t\t1993;\n\t\t\t\t\t104(4):\n\t\t\t\t\t994\u2013\n\t\t\t\t\t1006.","DOI":"10.1016\/0016-5085(93)90266-F"},{"key":"2021052618104376600_i1543-2165-145-6-664-b30","doi-asserted-by":"crossref","unstructured":"Li\n              TT,\n            \n            \n              Qiu\n              F,\n            \n            \n              Qian\n              ZR,\n            \n            \n              Wan\n              J,\n            \n            \n              Qi\n              XK,\n            \n            \n              Wu\n              BY.\n            \n          \n          Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors.\n\t\t\t\t\tWorld J Gasteroenterol.\n\t\t\t\t\t2014;\n\t\t\t\t\t20(1):\n\t\t\t\t\t118\u2013\n\t\t\t\t\t125.","DOI":"10.3748\/wjg.v20.i1.118"},{"key":"2021052618104376600_i1543-2165-145-6-664-b31","doi-asserted-by":"crossref","unstructured":"Nomura\n              Y,\n            \n            \n              Nakashima\n              O,\n            \n            \n              Akiba\n              J,\n            \n            et al.\n          \n          Clinicopathological features of neoplasms with neuroendocrine differentiation occurring in the liver.\n\t\t\t\t\tJ Clin Pathol.\n\t\t\t\t\t2017;\n\t\t\t\t\t70(7):\n\t\t\t\t\t563\u2013\n\t\t\t\t\t570.","DOI":"10.1136\/jclinpath-2016-203941"},{"key":"2021052618104376600_i1543-2165-145-6-664-b32","doi-asserted-by":"crossref","unstructured":"Choi\n              GH,\n            \n            \n              Ann\n              SY,\n            \n            \n              Lee\n              SI,\n            \n            \n              Kim\n              SB,\n            \n            \n              Song\n              IH.\n            \n          \n          Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: case report and review of the literature.\n\t\t\t\t\tWorld J Gastroenterol.\n\t\t\t\t\t2016;\n\t\t\t\t\t22(41):\n\t\t\t\t\t9229\u2013\n\t\t\t\t\t9234.","DOI":"10.3748\/wjg.v22.i41.9229"},{"key":"2021052618104376600_i1543-2165-145-6-664-b33","doi-asserted-by":"crossref","unstructured":"Okumura\n              Y,\n            \n            \n              Kohashi\n              K,\n            \n            \n              Wang\n              H,\n            \n            et al.\n          \n          Combined primary hepatic neuroendocrine carcinoma and hepatocellular carcinoma with aggressive biological behavior (adverse clinical course): a case report.\n\t\t\t\t\tPathol Res Pract.\n\t\t\t\t\t2017;\n\t\t\t\t\t213(10):\n\t\t\t\t\t1322\u2013\n\t\t\t\t\t1326.","DOI":"10.1016\/j.prp.2017.06.001"},{"key":"2021052618104376600_i1543-2165-145-6-664-b34","doi-asserted-by":"crossref","unstructured":"Zheng\n              Z,\n            \n            \n              Chen\n              C,\n            \n            \n              Li\n              B,\n            \n            et al.\n          \n          Biliary neuroendocrine neoplasms: clinical profiles, management, and analysis of prognostic factors.\n\t\t\t\t\tFront Oncol.\n\t\t\t\t\t2019;\n\t\t\t\t\t9:\n\t\t\t\t\t38.","DOI":"10.3389\/fonc.2019.00038"},{"key":"2021052618104376600_i1543-2165-145-6-664-b35","doi-asserted-by":"crossref","unstructured":"Reid\n              MD,\n            \n            \n              Roa\n              JC,\n            \n            \n              Memis\n              B,\n            \n            et al.\n          \n          Neuroendocrine neoplasms of the gallbladder. an immunohistochemical and clinicopathologic analysis of 29 cases [abstract 784].\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2017;\n\t\t\t\t\t30(S2):\n\t\t\t\t\t157\u2013\n\t\t\t\t\t210","DOI":"10.1038\/modpathol.2016.249"},{"key":"2021052618104376600_i1543-2165-145-6-664-b36","doi-asserted-by":"crossref","unstructured":"Adsay\n              V,\n            \n            \n              Jang\n              K,\n            \n            \n              Roa\n              JC,\n            \n            et al.\n          \n          Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are \u22651.0 cm): Clinicopathologic and immunohistochemical analysis of 123 cases.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2012;\n\t\t\t\t\t36(9):\n\t\t\t\t\t1279\u2013\n\t\t\t\t\t1301.","DOI":"10.1097\/PAS.0b013e318262787c"},{"key":"2021052618104376600_i1543-2165-145-6-664-b37","doi-asserted-by":"crossref","unstructured":"Kanetkar\n              AV,\n            \n            \n              Patkar\n              S,\n            \n            \n              Khobragade\n              KH,\n            \n            \n              Ostwal\n              V,\n            \n            \n              Ramaswamy\n              A,\n            \n            \n              Goel\n              M.\n            \n          \n          Neuroendocrine carcinoma of gallbladder: a step beyond palliative therapy, experience of 25 cases.\n\t\t\t\t\tJ Gastrointest Cancer.\n\t\t\t\t\t2019;\n\t\t\t\t\t50(2):\n\t\t\t\t\t298\u2013\n\t\t\t\t\t303.","DOI":"10.1007\/s12029-018-0070-y"},{"key":"2021052618104376600_i1543-2165-145-6-664-b38","doi-asserted-by":"crossref","unstructured":"Terada\n              T.\n            \n          \n          Small cell carcinoma of the ileum that developed 10 years after total gastrectomy for gastric signet-ring cell carcinoma.\n\t\t\t\t\tAppl Immunohistochem Mol Morphol.\n\t\t\t\t\t2012;\n\t\t\t\t\t20(6):\n\t\t\t\t\t618.","DOI":"10.1097\/PAI.0b013e31823eb34f"},{"key":"2021052618104376600_i1543-2165-145-6-664-b39","doi-asserted-by":"crossref","unstructured":"O'Shea\n              T,\n            \n            \n              Druce\n              M.\n            \n          \n          When should genetic testing be performed in patients with neuroendocrine tumours?\n          \n            Rev Endocr Metab Disord\n          .\n\t\t\t\t\t2017;\n\t\t\t\t\t18(4):\n\t\t\t\t\t499\u2013\n\t\t\t\t\t515.","DOI":"10.1007\/s11154-017-9430-3"},{"key":"2021052618104376600_i1543-2165-145-6-664-b40","doi-asserted-by":"crossref","unstructured":"Manguso\n              N,\n            \n            \n              Johnson\n              J,\n            \n            \n              Harit\n              A,\n            \n            et al.\n          \n          Prognostic factors associated with outcomes in small bowel neuroendocrine tumors.\n\t\t\t\t\tAm Surg.\n\t\t\t\t\t2017;\n\t\t\t\t\t83(10):\n\t\t\t\t\t1174\u2013\n\t\t\t\t\t1178.","DOI":"10.1177\/000313481708301033"},{"key":"2021052618104376600_i1543-2165-145-6-664-b41","doi-asserted-by":"crossref","unstructured":"Frilling\n              A,\n            \n            \n              Modlin\n              IM,\n            \n            \n              Kidd\n              M,\n            \n            et al.\n          \n          Recommendations for management of patients with neuroendocrine liver metastases.\n\t\t\t\t\tLancet Oncol.\n\t\t\t\t\t2014;\n\t\t\t\t\t15(1):\n\t\t\t\t\t8.","DOI":"10.1016\/S1470-2045(13)70362-0"},{"key":"2021052618104376600_i1543-2165-145-6-664-b42","doi-asserted-by":"crossref","unstructured":"Dasari\n              A,\n            \n            \n              Shen\n              C,\n            \n            \n              Halperin\n              D,\n            \n            et al.\n          \n          Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united states.\n\t\t\t\t\tJAMA Oncol.\n\t\t\t\t\t2017;\n\t\t\t\t\t3(10):\n\t\t\t\t\t1335\u2013\n\t\t\t\t\t1342.","DOI":"10.1001\/jamaoncol.2017.0589"},{"key":"2021052618104376600_i1543-2165-145-6-664-b43","doi-asserted-by":"crossref","unstructured":"Berardi\n              RS.\n            \n          \n          Carcinoid tumors of the colon (exclusive of the rectum): review of the literature.\n\t\t\t\t\tDis Colon Rectum.\n\t\t\t\t\t1972;\n\t\t\t\t\t15(5):\n\t\t\t\t\t383\u2013\n\t\t\t\t\t391.","DOI":"10.1007\/BF02587418"},{"key":"2021052618104376600_i1543-2165-145-6-664-b44","doi-asserted-by":"crossref","unstructured":"Kojima\n              M,\n            \n            \n              Ikeda\n              K,\n            \n            \n              Saito\n              N,\n            \n            et al.\n          \n          Neuroendocrine tumors of the large intestine: clinicopathological features and predictive factors of lymph node metastasis.\n\t\t\t\t\tFront Oncol.\n\t\t\t\t\t2016;\n\t\t\t\t\t6:\n\t\t\t\t\t173.","DOI":"10.3389\/fonc.2016.00173"},{"key":"2021052618104376600_i1543-2165-145-6-664-b45","doi-asserted-by":"crossref","unstructured":"Gaspar\n              R,\n            \n            \n              Santos-Antunes\n              J,\n            \n            \n              Marques\n              M,\n            \n            et al.\n          \n          Mixed adenoneuroendocrine tumor of the rectum in an ulcerative colitis patient.\n\t\t\t\t\tGE Port J Gastroenterol.\n\t\t\t\t\t2019;\n\t\t\t\t\t26(2):\n\t\t\t\t\t125\u2013\n\t\t\t\t\t127.","DOI":"10.1159\/000489409"},{"key":"2021052618104376600_i1543-2165-145-6-664-b46","doi-asserted-by":"crossref","unstructured":"Wong\n              M,\n            \n            \n              Larson\n              BK,\n            \n            \n              Dhall\n              D.\n            \n          \n          Neuroendocrine proliferations in inflammatory bowel disease: differentiating neuroendocrine tumours from neuroendocrine cell micronests.\n\t\t\t\t\tHistopathology.\n\t\t\t\t\t2019;\n\t\t\t\t\t74(3):\n\t\t\t\t\t415\u2013\n\t\t\t\t\t423.","DOI":"10.1111\/his.13769"},{"key":"2021052618104376600_i1543-2165-145-6-664-b47","doi-asserted-by":"crossref","unstructured":"Klas\n              JV,\n            \n            \n              Rothenberger\n              DA,\n            \n            \n              Wong\n              WD,\n            \n            \n              Madoff\n              RD.\n            \n          \n          Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.\n\t\t\t\t\tCancer.\n\t\t\t\t\t1999;\n\t\t\t\t\t85(8):\n\t\t\t\t\t1686\u2013\n\t\t\t\t\t1693.","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7"},{"key":"2021052618104376600_i1543-2165-145-6-664-b48","doi-asserted-by":"crossref","unstructured":"Kim\n              ST,\n            \n            \n              Ha\n              SY,\n            \n            \n              Lee\n              J,\n            \n            et al.\n          \n          The clinicopathologic features and treatment of 607 hindgut neuroendocrine tumor (NET) patients at a single institution.\n\t\t\t\t\tMedicine (Baltimore).\n\t\t\t\t\t2016;\n\t\t\t\t\t95(19):\n\t\t\t\t\te3534.","DOI":"10.1097\/MD.0000000000003534"},{"key":"2021052618104376600_i1543-2165-145-6-664-b49","doi-asserted-by":"crossref","unstructured":"Nakahara\n              H,\n            \n            \n              Moriya\n              Y,\n            \n            \n              Shinkai\n              T,\n            \n            \n              Hirota\n              T.\n            \n          \n          Small cell carcinoma of the anus in a human HIV carrier: report of a case.\n\t\t\t\t\tSurg Today.\n\t\t\t\t\t1993;\n\t\t\t\t\t23(1):\n\t\t\t\t\t85\u2013\n\t\t\t\t\t88.","DOI":"10.1007\/BF00309007"},{"key":"2021052618104376600_i1543-2165-145-6-664-b50","unstructured":"Marcus\n              DM,\n            \n            \n              Edgar\n              MA,\n            \n            \n              Hawk\n              NN,\n            \n            \n              Sullivan\n              PS,\n            \n            \n              Stapleford\n              LJ.\n            \n          \n          Small cell carcinoma of the anus in the setting of prior squamous dysplasia and carcinoma in situ.\n\t\t\t\t\tJ Gastrointest Oncol.\n\t\t\t\t\t2013;\n\t\t\t\t\t4(2):\n\t\t\t\t\tE1\u2013\n\t\t\t\t\tE4."},{"key":"2021052618104376600_i1543-2165-145-6-664-b51","doi-asserted-by":"crossref","unstructured":"Cimino-Mathews\n              A,\n            \n            \n              Sharma\n              R,\n            \n            \n              Illei\n              PB.\n            \n          \n          Detection of human papillomavirus in small cell carcinomas of the anus and rectum.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2012;\n\t\t\t\t\t36(7):\n\t\t\t\t\t1087\u2013\n\t\t\t\t\t1092.","DOI":"10.1097\/PAS.0b013e3182549b6d"},{"key":"2021052618104376600_i1543-2165-145-6-664-b52","doi-asserted-by":"crossref","unstructured":"Pasternak\n              S,\n            \n            \n              Carter\n              MD,\n            \n            \n              Ly\n              TY,\n            \n            \n              Doucette\n              S,\n            \n            \n              Walsh\n              NM.\n            \n          \n          Immunohistochemical profiles of different subsets of merkel cell carcinoma.\n\t\t\t\t\tHum Pathol.\n\t\t\t\t\t2018;\n\t\t\t\t\t82:\n\t\t\t\t\t232\u2013\n\t\t\t\t\t238.","DOI":"10.1016\/j.humpath.2018.07.022"},{"key":"2021052618104376600_i1543-2165-145-6-664-b53","doi-asserted-by":"crossref","unstructured":"Shia\n              J.\n            \n          \n          An update on tumors of the anal canal.\n\t\t\t\t\tArch Pathol Lab Med.\n\t\t\t\t\t2010;\n\t\t\t\t\t134(11):\n\t\t\t\t\t1601\u2013\n\t\t\t\t\t1611.","DOI":"10.5858\/2009-0668-RAR.1"},{"key":"2021052618104376600_i1543-2165-145-6-664-b54","doi-asserted-by":"crossref","unstructured":"Gut\n              P,\n            \n            \n              Walig\u00f3rska-Stachura\n              J,\n            \n            \n              Czarnywojtek\n              A,\n            \n            et al.\n          \n          Hindgut neuroendocrine neoplasms \u2013 characteristics and prognosis.\n\t\t\t\t\tArch Med Sci.\n\t\t\t\t\t2017;\n\t\t\t\t\t13(6):\n\t\t\t\t\t1427\u2013\n\t\t\t\t\t1432.","DOI":"10.5114\/aoms.2017.64979"},{"key":"2021052618104376600_i1543-2165-145-6-664-b55","doi-asserted-by":"crossref","unstructured":"Stinner\n              B,\n            \n            \n              Rothmund\n              M.\n            \n          \n          Neuroendocrine tumours (carcinoids) of the appendix.\n\t\t\t\t\tBest Pract Res Clin Gastroenterol.\n\t\t\t\t\t2005;\n\t\t\t\t\t19(5):\n\t\t\t\t\t729\u2013\n\t\t\t\t\t738.","DOI":"10.1016\/j.bpg.2005.06.003"},{"key":"2021052618104376600_i1543-2165-145-6-664-b56","doi-asserted-by":"crossref","unstructured":"Moris\n              D,\n            \n            \n              Tsilimigras\n              DI,\n            \n            \n              Vagios\n              S,\n            \n            et al.\n          \n          Neuroendocrine neoplasms of the appendix: a review of the literature.\n\t\t\t\t\tAnticancer Res.\n\t\t\t\t\t2018;\n\t\t\t\t\t38(2):\n\t\t\t\t\t601\u2013\n\t\t\t\t\t611.","DOI":"10.21873\/anticanres.12264"},{"key":"2021052618104376600_i1543-2165-145-6-664-b57","doi-asserted-by":"crossref","unstructured":"Torlakovic\n              E,\n            \n            \n              Snover\n              DC.\n            \n          \n          Serrated adenomatous polyposis in humans.\n\t\t\t\t\tGastroenterology.\n\t\t\t\t\t1996;\n\t\t\t\t\t110(3):\n\t\t\t\t\t748\u2013\n\t\t\t\t\t755.","DOI":"10.1053\/gast.1996.v110.pm8608884"},{"key":"2021052618104376600_i1543-2165-145-6-664-b58","doi-asserted-by":"crossref","unstructured":"Pai\n              RK,\n            \n            \n              Hartman\n              DJ,\n            \n            \n              Gonzalo\n              DH,\n            \n            et al.\n          \n          Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix.\n\t\t\t\t\tHum Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t45(2):\n\t\t\t\t\t227\u2013\n\t\t\t\t\t235.","DOI":"10.1016\/j.humpath.2013.10.021"},{"key":"2021052618104376600_i1543-2165-145-6-664-b59","doi-asserted-by":"crossref","unstructured":"Carr\n              NJ,\n            \n            \n              Cecil\n              TD,\n            \n            \n              Mohamed\n              F,\n            \n            et al.\n          \n          A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: The results of the peritoneal surface oncology group international (PSOGI) modified Delphi process.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2016;\n\t\t\t\t\t40(1):\n\t\t\t\t\t14\u2013\n\t\t\t\t\t26.","DOI":"10.1097\/PAS.0000000000000535"},{"key":"2021052618104376600_i1543-2165-145-6-664-b60","doi-asserted-by":"crossref","unstructured":"Yantiss\n              RK,\n            \n            \n              Shia\n              J,\n            \n            \n              Klimstra\n              DS,\n            \n            \n              Hahn\n              HP,\n            \n            \n              Odze\n              RD,\n            \n            \n              Misdraji\n              J.\n            \n          \n          Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2009;\n\t\t\t\t\t33(2):\n\t\t\t\t\t248\u2013\n\t\t\t\t\t255.","DOI":"10.1097\/PAS.0b013e31817ec31e"},{"key":"2021052618104376600_i1543-2165-145-6-664-b61","doi-asserted-by":"crossref","unstructured":"Shaib\n              WL,\n            \n            \n              Assi\n              R,\n            \n            \n              Shamseddine\n              A,\n            \n            et al.\n          \n          Appendiceal mucinous neoplasms: diagnosis and management.\n\t\t\t\t\tOncologist.\n\t\t\t\t\t2017;\n\t\t\t\t\t22(9):\n\t\t\t\t\t1107\u2013\n\t\t\t\t\t1116.","DOI":"10.1634\/theoncologist.2017-0081"},{"key":"2021052618104376600_i1543-2165-145-6-664-b62","doi-asserted-by":"crossref","unstructured":"Liu\n              X,\n            \n            \n              Mody\n              K,\n            \n            \n              de Abreu\n              FB,\n            \n            et al.\n          \n          Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.\n\t\t\t\t\tClin Chem.\n\t\t\t\t\t2014;\n\t\t\t\t\t60(7):\n\t\t\t\t\t1004\u2013\n\t\t\t\t\t1011.","DOI":"10.1373\/clinchem.2014.225565"},{"key":"2021052618104376600_i1543-2165-145-6-664-b63","doi-asserted-by":"crossref","unstructured":"Davison\n              JM,\n            \n            \n              Choudry\n              HA,\n            \n            \n              Pingpank\n              JF,\n            \n            et al.\n          \n          Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t27(11):\n\t\t\t\t\t1521\u2013\n\t\t\t\t\t1539.","DOI":"10.1038\/modpathol.2014.37"},{"key":"2021052618104376600_i1543-2165-145-6-664-b64","doi-asserted-by":"crossref","unstructured":"Yozu\n              M,\n            \n            \n              Johncilla\n              ME,\n            \n            \n              Srivastava\n              A,\n            \n            et al.\n          \n          Histologic and outcome study supports reclassifying appendiceal goblet cell carcinoids as goblet cell adenocarcinomas, and grading and staging similarly to colonic adenocarcinomas.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2018;\n\t\t\t\t\t42(7):\n\t\t\t\t\t898\u2013\n\t\t\t\t\t910.","DOI":"10.1097\/PAS.0000000000001056"},{"key":"2021052618104376600_i1543-2165-145-6-664-b65","doi-asserted-by":"crossref","unstructured":"Tang\n              LH,\n            \n            \n              Shia\n              J,\n            \n            \n              Soslow\n              RA,\n            \n            et al.\n          \n          Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2008;\n\t\t\t\t\t32(10):\n\t\t\t\t\t1429\u2013\n\t\t\t\t\t1443.","DOI":"10.1097\/PAS.0b013e31817f1816"},{"key":"2021052618104376600_i1543-2165-145-6-664-b66","doi-asserted-by":"crossref","unstructured":"Roth\n              RM,\n            \n            \n              Hampel\n              H,\n            \n            \n              Arnold\n              CA,\n            \n            \n              Yearsley\n              MM,\n            \n            \n              Marsh\n              WL,\n            \n            \n              Frankel\n              WL.\n            \n          \n          A modified lynch syndrome screening algorithm in colon cancer: BRAF immunohistochemistry is efficacious and cost beneficial.\n\t\t\t\t\tAm J Clin Pathol.\n\t\t\t\t\t2015;\n\t\t\t\t\t143(3):\n\t\t\t\t\t336\u2013\n\t\t\t\t\t343.","DOI":"10.1309\/AJCP4D7RXOBHLKGJ"},{"key":"2021052618104376600_i1543-2165-145-6-664-b67","doi-asserted-by":"crossref","unstructured":"Walsh\n              S.\n            \n          \n          The pathology of Lynch syndrome.\n\t\t\t\t\tDiagnostic Histopathology.\n\t\t\t\t\t2015;\n\t\t\t\t\t21(4):\n\t\t\t\t\t161\u2013\n\t\t\t\t\t164.","DOI":"10.1016\/j.mpdhp.2015.04.007"},{"key":"2021052618104376600_i1543-2165-145-6-664-b68","doi-asserted-by":"crossref","unstructured":"Sinicrope\n              FA.\n            \n          \n          DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer.\n\t\t\t\t\tNat Rev Clin Oncol.\n\t\t\t\t\t2010;\n\t\t\t\t\t7(3):\n\t\t\t\t\t174\u2013\n\t\t\t\t\t177.","DOI":"10.1038\/nrclinonc.2009.235"},{"key":"2021052618104376600_i1543-2165-145-6-664-b69","doi-asserted-by":"crossref","unstructured":"Le\n              DT,\n            \n            \n              Uram\n              JN,\n            \n            \n              Wang\n              H,\n            \n            et al.\n          \n          PD-1 blockade in tumors with mismatch-repair deficiency.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2015;\n\t\t\t\t\t372(26):\n\t\t\t\t\t2509\u2013\n\t\t\t\t\t2520.","DOI":"10.1056\/NEJMoa1500596"},{"key":"2021052618104376600_i1543-2165-145-6-664-b70","doi-asserted-by":"crossref","unstructured":"Sarode\n              VR,\n            \n            \n              Robinson\n              L.\n            \n          \n          Screening for lynch syndrome by immunohistochemistry of mismatch repair proteins: significance of indeterminate result and correlation with mutational studies.\n\t\t\t\t\tArch Pathol Lab Med.\n\t\t\t\t\t2019;\n\t\t\t\t\t143(10):\n\t\t\t\t\t1225\u2013\n\t\t\t\t\t1233.","DOI":"10.5858\/arpa.2018-0201-OA"},{"key":"2021052618104376600_i1543-2165-145-6-664-b71","doi-asserted-by":"crossref","unstructured":"Plum\n              PS,\n            \n            \n              Gebauer\n              F,\n            \n            \n              Kr\u00e4mer\n              M,\n            \n            et al.\n          \n          HER2\/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.\n\t\t\t\t\tBMC Cancer.\n\t\t\t\t\t2019;\n\t\t\t\t\t19(1):\n\t\t\t\t\t38.","DOI":"10.1186\/s12885-018-5242-4"},{"key":"2021052618104376600_i1543-2165-145-6-664-b72","doi-asserted-by":"crossref","unstructured":"van Hagen\n              P,\n            \n            \n              Hulshof\n              MC,\n            \n            \n              van Lanschot\n              JJ,\n            \n            et al.\n          \n          Preoperative chemoradiotherapy for esophageal or junctional cancer.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2012;\n\t\t\t\t\t366(22):\n\t\t\t\t\t2074\u2013\n\t\t\t\t\t2084.","DOI":"10.1056\/NEJMoa1112088"},{"key":"2021052618104376600_i1543-2165-145-6-664-b73","doi-asserted-by":"crossref","unstructured":"Iizasa\n              H,\n            \n            \n              Nanbo\n              A,\n            \n            \n              Nishikawa\n              J,\n            \n            \n              Jinushi\n              M,\n            \n            \n              Yoshiyama\n              H.\n            \n          \n          Epstein-Barr virus (EBV)-associated gastric carcinoma.\n\t\t\t\t\tViruses.\n\t\t\t\t\t2012;\n\t\t\t\t\t4(12):\n\t\t\t\t\t3420\u2013\n\t\t\t\t\t3439.","DOI":"10.3390\/v4123420"},{"key":"2021052618104376600_i1543-2165-145-6-664-b74","doi-asserted-by":"crossref","unstructured":"Huh\n              CW,\n            \n            \n              Jung\n              DH,\n            \n            \n              Kim\n              H,\n            \n            et al.\n          \n          Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer.\n\t\t\t\t\tJ Surg Oncol.\n\t\t\t\t\t2016;\n\t\t\t\t\t114(6):\n\t\t\t\t\t769\u2013\n\t\t\t\t\t772.","DOI":"10.1002\/jso.24385"},{"key":"2021052618104376600_i1543-2165-145-6-664-b75","doi-asserted-by":"crossref","unstructured":"Saito\n              R,\n            \n            \n              Abe\n              H,\n            \n            \n              Kunita\n              A,\n            \n            \n              Yamashita\n              H,\n            \n            \n              Seto\n              Y,\n            \n            \n              Fukayama\n              M.\n            \n          \n          Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in epstein-barr virus-associated gastric cancer: the prognostic implications.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2017;\n\t\t\t\t\t30(3):\n\t\t\t\t\t427\u2013\n\t\t\t\t\t439.","DOI":"10.1038\/modpathol.2016.202"},{"key":"2021052618104376600_i1543-2165-145-6-664-b76","doi-asserted-by":"crossref","unstructured":"De Mello\n              RA,\n            \n            \n              Lordick\n              F,\n            \n            \n              Muro\n              K,\n            \n            \n              Janjigian\n              YY.\n            \n          \n          Current and future aspects of immunotherapy for esophageal and gastric malignancies.\n\t\t\t\t\tAm Soc Clin Oncol Educ Book.\n\t\t\t\t\t2019(39):\n\t\t\t\t\t237\u2013\n\t\t\t\t\t247.","DOI":"10.1200\/EDBK_236699"},{"key":"2021052618104376600_i1543-2165-145-6-664-b77","doi-asserted-by":"crossref","unstructured":"Bartley\n              AN,\n            \n            \n              Washington\n              MK,\n            \n            \n              Colasacco\n              C,\n            \n            et al.\n          \n          HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2017;\n\t\t\t\t\t35(4):\n\t\t\t\t\t446\u2013\n\t\t\t\t\t464.","DOI":"10.1200\/JCO.2016.69.4836"},{"key":"2021052618104376600_i1543-2165-145-6-664-b78","doi-asserted-by":"crossref","unstructured":"Jun\n              S,\n            \n            \n              Lee\n              E,\n            \n            \n              Kim\n              M,\n            \n            et al.\n          \n          Lynch syndrome-related small intestinal adenocarcinomas.\n\t\t\t\t\tOncotarget.\n\t\t\t\t\t2017;\n\t\t\t\t\t8(13):\n\t\t\t\t\t21483\u2013\n\t\t\t\t\t21500.","DOI":"10.18632\/oncotarget.15277"},{"key":"2021052618104376600_i1543-2165-145-6-664-b79","doi-asserted-by":"crossref","unstructured":"Agaimy\n              A,\n            \n            \n              Rau\n              TT,\n            \n            \n              Hartmann\n              A,\n            \n            \n              Stoehr\n              R.\n            \n          \n          SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t38(7):\n\t\t\t\t\t910\u2013\n\t\t\t\t\t920.","DOI":"10.1097\/PAS.0000000000000173"},{"key":"2021052618104376600_i1543-2165-145-6-664-b80","doi-asserted-by":"crossref","unstructured":"Bellizzi\n              AM.\n            \n          \n          Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms.\n\t\t\t\t\tSemin Diagn Pathol.\n\t\t\t\t\t2013;\n\t\t\t\t\t30(4):\n\t\t\t\t\t329\u2013\n\t\t\t\t\t361.","DOI":"10.1053\/j.semdp.2013.11.001"},{"key":"2021052618104376600_i1543-2165-145-6-664-b81","doi-asserted-by":"crossref","unstructured":"Piawah\n              S,\n            \n            \n              Venook\n              AP.\n            \n          \n          Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.\n\t\t\t\t\tCancer.\n\t\t\t\t\t2019;\n\t\t\t\t\t125(23):\n\t\t\t\t\t4139\u2013\n\t\t\t\t\t4147.","DOI":"10.1002\/cncr.32163"},{"key":"2021052618104376600_i1543-2165-145-6-664-b82","doi-asserted-by":"crossref","unstructured":"Luu\n              L-J,\n            \n            \n              Price\n              TJ.\n            \n          \n          \n            BRAF mutation and its importance in colorectal cancer, advances in the molecular understanding of colorectal cancer\n          .\n\t\t\t\t\tLondon:\n\t\t\t\t\tIntechOpen Limited;2019.","DOI":"10.5772\/intechopen.82571"},{"key":"2021052618104376600_i1543-2165-145-6-664-b83","doi-asserted-by":"crossref","unstructured":"Hsu\n              H,\n            \n            \n              Thiam\n              TK,\n            \n            \n              Lu\n              Y,\n            \n            et al.\n          \n          Mutations of KRAS\/NRAS\/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.\n\t\t\t\t\tOncotarget.\n\t\t\t\t\t2016;\n\t\t\t\t\t7(16):\n\t\t\t\t\t22257\u2013\n\t\t\t\t\t22270.","DOI":"10.18632\/oncotarget.8076"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/145\/6\/664\/2835640\/i1543-2165-145-6-664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/145\/6\/664\/2835640\/i1543-2165-145-6-664.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:34Z","timestamp":1764790894000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/145\/6\/article-p664.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":83,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2019-0665-ra","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}